H.R. 8991

H.R. 8991: To amend section 2101 of title 28, United States Code, to set forth factors for stays pending appeal.

Introduced Jamie Raskin (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8991 aims to amend section 2101 of title 28 in the United States Code. The bill sets forth specific factors that courts should consider when deciding whether to grant stays pending appeal. This means that when a party appeals a court decision, the bill would guide judges on how to evaluate requests to pause enforcement of the ruling while the appeal is being processed.

Positive Media Summary

Some media outlets have praised H.R. 8991 for providing clearer guidelines for judges, which could lead to more consistent and fair decisions regarding stays pending appeal. Supporters argue that this will enhance the judicial process and help parties understand what to expect during appeals.

Negative Media Summary

Critics of H.R. 8991 have raised concerns that the new factors could complicate the appeals process and potentially delay justice. Some argue that it may limit the discretion of judges, leading to unintended consequences in specific cases where a stay is warranted.

Conflict of Interest Analysis Deep Analysis
2/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Law

The analysis of H.R. 8991, sponsored by Jamie Raskin, reveals no direct industry overlaps between the bill's subject matter and the sponsor's top donor industries. The bill aims to amend legal procedures regarding stays pending appeal, which does not appear to intersect with the interests of Raskin's primary donors. While there is significant lobbying activity in the policy area, including $120,000 from CEDIA, the lack of direct financial ties to the bill's content suggests a low risk of conflict of interest. Voters should be aware that while lobbying exists, it does not directly influence the sponsor's legislative agenda based on the available data.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
FRIENDS COMMITTEE ON NATIONAL LEGISLATION FRIENDS COMMITTEE ON NATIONAL LEGISLATION $1,000,000
CEDIA CEDIA $120,000
KNOA PHARMA LLC MERCURY PUBLIC AFFAIRS, LLC undisclosed
HELIX DEFENSE CROSS POTOMAC CONSULTING LLC undisclosed
SUR HOLDINGS BGR GOVERNMENT AFFAIRS undisclosed
GLOBAL KRATOM COALITION BGR GOVERNMENT AFFAIRS undisclosed
GIBSON, DUNN & CRUTCHER, LLP ON BEHALF OF CURATIVE INC. BGR GOVERNMENT AFFAIRS undisclosed
SEISMIC SOFTWARE, INC. MILLER STRATEGIES, LLC undisclosed
ALBERS AEROSPACE BGR GOVERNMENT AFFAIRS undisclosed
PALANTIR TECHNOLOGIES, INC. AVOQ, LLC undisclosed
RENAL CARE 360 KILPATRICK TOWNSEND & STOCKTON undisclosed
DEXCOM BGR GOVERNMENT AFFAIRS undisclosed
CITY OF PHILADELPHIA BGR GOVERNMENT AFFAIRS undisclosed
ORCA BIO BGR GOVERNMENT AFFAIRS undisclosed
IONQ, INC. IONQ, INC. undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Jamie Raskin, ranked by total contributions.

Health Professionals $120,000,000
Individuals: $120,000,000 PACs: $0
Retired $37,500,000
Individuals: $37,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us